Evidence map›Paper›PMID 37421280›Full record

ArticleJournal of the American Heart Association2023

Adenosine A

Kei Akiyoshi, Tomonari Fujimori, Xiuping Fu, Aparna P Shah, Atsushi Yamaguchi, Charles Steenbergen, Lakshmi Santhanam, Dan Berkowitz, Eric Tuday, Jay M Baraban and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Kei AkiyoshiDepartment of Anesthesiology and Critical Care Medicine Johns Hopkins School of Medicine Baltimore MD USA.
Tomonari FujimoriDepartment of Anesthesiology and Critical Care Medicine Johns Hopkins School of Medicine Baltimore MD USA.
Xiuping FuDepartment of Intelligent Medical Engineering, School of Life Science Tiangong University Tianjin China.
Aparna P ShahSolomon H. Snyder Department of Neuroscience Johns Hopkins School of Medicine Baltimore MD USA.ORCID 0000-0002-7645-0775
Atsushi YamaguchiDepartment of Cardiovascular Surgery, Saitama Medical Center Jichi Medical University Saitama Japan.
Charles SteenbergenDepartment of Pathology Johns Hopkins School of Medicine Baltimore MD USA.ORCID 0000-0001-6654-325X
Lakshmi SanthanamDepartment of Anesthesiology and Critical Care Medicine Johns Hopkins School of Medicine Baltimore MD USA.ORCID 0000-0002-2097-9397
Dan BerkowitzDepartment of Anesthesiology and Perioperative Medicine The University of Alabama at Birmingham Birmingham AL USA.ORCID 0000-0003-2232-9416
Eric TudayDivision of Cardiovascular Medicine, Department of Internal Medicine, School of Medicine University of Utah Salt Lake City UT USA.
Jay M BarabanDepartment of Intelligent Medical Engineering, School of Life Science Tiangong University Tianjin China.ORCID 0000-0002-8165-2638
Samarjit DasDepartment of Anesthesiology and Critical Care Medicine Johns Hopkins School of Medicine Baltimore MD USA.ORCID 0000-0002-4377-2823
Johns Hopkins University · USJichi Medical University · JPTiangong University · CNUniversity of Alabama at Birmingham · USUniversity of Utah · US

Funding

Sex differences in the impact of frailty on vaccine-induced immune responses in community-dwelling older adultsU54AG062333 · NIA · JOHNS HOPKINS UNIVERSITY · PI PEKOSZ, ANDREW S. · 2018 to 2022
$8.9M
Exosome-based Non-traditional Technologies Towards Multi-Parametric andIntegrated Approaches for SARS-CoV-2U18TR003780 · NCATS · JOHNS HOPKINS UNIVERSITY · PI DAS, SAMARJIT · 2021 to 2022
$2.0M
American Heart Association-American Stroke Association 970850NCATS NIH HHS U18 TR003780NIA NIH HHS U54 AG062333
6 · The paper itself

Abstract

Background The identification of large-artery stiffness as a major, independent risk factor for cardiovascular disease-associated morbidity and death has focused attention on identifying therapeutic strategies to combat this disorder. Genetic manipulations that delete or inactivate the translin/trax microRNA-degrading enzyme confer protection against aortic stiffness induced by chronic ingestion of high-salt water (4%NaCl in drinking water for 3 weeks) or associated with aging. Therefore, there is heightened interest in identifying interventions capable of inhibiting translin/trax RNase activity, as these may have therapeutic efficacy in large-artery stiffness. Methods and Results Activation of neuronal adenosine A

Indexed as

MicroRNAsReceptor, Adenosine A2AAdenosineAnimalsAortaCarrier ProteinsDNA-Binding ProteinsHumansMiceWaterAdenosineCarrier ProteinsDNA-Binding ProteinsMicroRNAsReceptor, Adenosine A2AWateradenosine A2A receptormicroRNAmicroRNA‐181bmicroRNA degradationtranslin/traxvascular stiffness

Identifiers

PMID37421280
PMCPMC10382090
OpenAlexW4383619113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.